National Stock Number
6505-01-708-4226
National Stock Number (NSN) 6505-01-708-4226, or NIIN 017084226, (influenza virus vaccine) was assigned April 5, 2023 in the Federal Logistics Information System (FLIS). This NIIN is Available for Manual Assignment. This NSN does not replace any other NSNs.
There are 5 manufacturer part numbers associated with this NSN. None of the associated part number(s) are considered obsolete. The manufacturer part numbers were originally supplied by 2 suppliers. Today, 2 suppliers are listed as Active suppliers for this NSN. Of the active suppliers, 2 suppliers are deemed design controlled or valid supply parts.
This part number has not been procured by the US Government in over a year. There have been 6 contracts issued for this part number, with 6 awards given. The US Government has only awarded those contracts to one supplier. The last contract numbers awarded were: SPE2DP24P0152, SPE2DP24P0146, SPE2DP24P0055, SPE2DP23P0873, SPE2DP23P0855. The total value of the awarded contracts has been US$ 2,669.28.
There has been a small amount of demand for this national stock number. The demand for this NSN originated from less than 5 countries.
This NSN is assigned to Item Name Code (INC) 22781. [A VACCINE INDICATED FOR ACTIVE IMMUNIZATION FOR THE PREVENTION OF INFLUENZA DISEASE CAUSED BY INFLUENZA A SUBTYPE VIRUSES AND TYPE B VIRUSES CONTAINED IN THE VACCINE.]. This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. There is no information in the HMIRS; however, the NSN is in an FSC in Table II of Federal Standard 313 and an MSDS may be required by the user. The requirement for an MSDS is dependent on a hazard determination of the supplier or the intended end use of the product. NSN 6505017084226 does not contain precious metals.
This NSN is associated to Schedule B 3002200000: vaccines for human medicine. The Schedule B End Use is listed as pharmaceutical preparations. NAICS classification category 325414: biological product (except diagnostic) manufacturing.
This information was last updated on Jul 01, 2025.